We have not found any cost information for this lawyer
F. Christopher Mizzo is a partner in Kirkland & Ellis LLP’s Washington, D.C. office. His practice focuses on complex intellectual property litigation in the state and federal courts and the U.S. International Trade Commission, as well as counseling on technology-related matters. Mr. Mizzo’s experience includes representing clients ranging from Fortune Global 500 companies to smaller technology companies in cases involving a wide range of technologies, including pharmaceuticals (such as anti-hypertensive, anti-depressive, anti-cancer, anti-glaucoma and anti-HIV medications), biomedical devices, DRAM chips, cell phones, microchip manufacturing machines, and computer software and systems. Mr. Mizzo received his B.S. in Industrial Engineering summa cum laude from Rutgers University in 1996 and his J.D. from University of Virginia School of Law in 1999. Prior to joining Kirkland, Mr. Mizzo clerked for the Honorable William J. Martini in the United States District Court for the District of New Jersey.
We have not found any cost information for this lawyer
Quickly connect with top attorneys through our legal directory to get help with your legal issue.
Chat with a live agent who can match you with the right attorney for your legal needs.
Chat withState: District of Columbia
Acquired: 2007
No misconduct found
State: New York
Acquired: 2000
No misconduct found
655 Fifteenth Street, Washington, DC, 20005
655 15th St Nw, Suite 1200, Washington, DC, 20005-5701
Not Yet Reviewed
No Endorsement Data Available Yet
This attorney hasn't received any attorney endorsements recently on Avvo.
No Endorsement Data Available Yet
This attorney hasn't created any attorney endorsements recently on Avvo.
2009
U.S. Patent Case of the Year 2009 - Tafas v. Dudas, Managing Intellectual Property
2005 - Present
Partner, Kirkland & Ellis LLP A LAW FIRM SERVING GLOBAL CLIENTS
2004 - 2005
, The Honorable William J. Martini, U.S.D.J.
1999 - 2003
Associate, Fitzpatrick Cella Harper & Scinto
En banc appeal at the Federal Circuit pending.
En banc appeal at the Federal Circuit pending.
Vacated. En banc appeal pending.
Obtained highly favorable resolution when USPTO withdrew its proposed rules that we had challenged..
Obtained a favorable settlement after full discovery and GSK/ViiV asked the court for a preliminary injunction.
Obtained a favorable settlement in the midst of trial.
1999
JD - Juris Doctor
1996
BS - Bachelor of Science
2008
The PTO's New Rules Are Void: GlaxoSmithKline v. Dudas -- Stories from the Front
2005
Open Forum: Ask the Judges About Patent Litigation
2008
2002